Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 19/20 | 0.64 |
| ▸ | NPY1R | P25929 | 12/20 | 0.64 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.64 |
| ▸ | NPY2R | P49146 | 8/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31388270 | 0.94 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29376654 | 0.92 | NPY4R (0.50) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31465103 | 0.91 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30341658 | 0.91 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31663446 | 0.91 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30966840 | 0.91 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31064805 | 0.91 | NPY4R (0.50) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30661159 | 0.90 | NPY4R (0.62) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30237703 | 0.90 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30974435 | 0.90 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4192853-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | Boehringer Ingelheim International GmbH (DE) | 2023-06-14 | — | — | EP | claimed |
| CN-116171282-A | Soluble NPY2 receptor agonists | 勃林格殷格翰国际有限公司 | 2023-05-26 | — | — | CN | claimed |
| WO-2022029231-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-02-10 | — | — | WO | claimed |
| EP-4192853-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | Boehringer Ingelheim International GmbH (DE) | 2023-06-14 | — | — | EP | disclosed |
| CN-116171282-A | Soluble NPY2 receptor agonists | 勃林格殷格翰国际有限公司 | 2023-05-26 | — | — | CN | disclosed |
| WO-2022029231-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-02-10 | — | — | WO | disclosed |